Influence of mechanochemically modified doxorubicin and irradiation with frequency 40 MHz on doxorubicin-resistant Guerin's carcinoma

Experimental Oncology

Volumn 24, Issue 3, 2002, Pages 234-236

  Todor, I N ^a   Orel, V E ^b   Mikhailenko, V M ^a   Danko, M I ^b   Dzyatkovskaya, N N ^b  

^a R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

^b STATE INSTITUTION NATIONAL RESEARCH CENTER FOR RADIATION MEDICINE OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE   (Ukraine)

Author keywords

Doxorubicin resistant Guerin's carcinoma; Irradiation with frequency 40 MHz; Mechanochemically modified doxorubicin

Indexed keywords

DOXORUBICIN;

ANIMAL CELL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RADIOTHERAPY; CANCER RESISTANCE; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STRUCTURE; FREQUENCY MODULATION; GUERIN TUMOR; ION TRANSPORT; MALE; MECHANOCHEMICAL MODIFICATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; RELAXATION TIME; STRUCTURE ACTIVITY RELATION; SURFACE CHARGE; TIME; TUMOR VOLUME;

EID: 0036765333     PISSN: 02043564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Hortobagyi GN. Anthracyclines in the treatment of cancer. Drugs 1997; 54: 1-7
2. Solyanik GI, Todor IN, Kulik GI, Chekhun VF. Selective mechanism of the development of the resistance of Guerin carcinoma to doxorubicin. Exp Oncol 1999; 21: 264-8 (In Russian).
3. Richardson DS, Johnson SA. Anthracycline in haematology: preclinical toxicity and delivery systems. Blood Rev 1997; 11: 201-23.
4. Pacilo C, Florio S, Pagnini U, Crispino A, Claudio PP, Pacilio G, Pagnini G. Modification of membrane fluidity and depolarization by some anthracyclines in different cell lines. Anticancer Res 1998; 18: 4027-34.
5. Fonseca MG, Storm, Hennink WE, Gerritsen WR, Haisma HI. Cationic polymeric gene delivery of beta-glucuronidase for doxorubicine prodrug therapy. J Gene Med 1999; 1: 407-14.
6. Pasquinelli P, Petrini M, Mattii L, Galimberti S, Saviozzi M, Malvaldi G. Biological effects of PEMF (pulsing electromagnetic field): an attempt to modify cell resistance to anticancer agents. J Env Path Tox Oncol 1993; 12: 193-7.
7. Kondo S, Hosaka S, Kuzuya M. Mechanochemical solid-state polymerization. VIII. Novel composite polymeric prodrugs prepared by mechanochemical polymerization in the presence of pharmaceutical aids. Chem Pharm Bull 1998; 46: 669-73.
8. Shakhtshneider TP, Vasilchenko MA, Politov AA, Boldyrev VV. Mechanochemical preparation of drug-carrier solid dispersions. J Therm Anal 1997; 48: 491-501.
9. Dubinskaya AM. Transformation of organic compounds upon the action of mechanical exertion. Uspehi Khimii 1999; 68: 708-24 (In Russian).
10. Orel VE, Dzyatkovska NM, Danko MI. Experimental research of mechanochemically modified doxorubicine. Pharm Zh 2000; 2: 75-8 (In Ukrainian).
11. Mookvich AN, Osipova LA, Osinskiy SP. Antitumor effect and thermotolerance caused by hyperthermia applied in different time on Guerin carcinoma bearing rats. Exp Oncol 1991; 14: 65-8 (In Russian).
12. Derome A.E. Modern NMR techniques for chemistry research. Oxford: Program Press 1992. 403 p.
13. Sivcovich SA, Orel VE, Dzyatkovskaya NN, Danko MI, Kindzelssky YP. Mechanochemical technology activation of anticancer anthracycline antibiotic doxorubicin for polychemotherapy of malignant limphoma. Med Biol Eng Computing 1999; 37 (Suppl 2): 40-1.
14. Serafino A, Sinibaldi-Vallebona P, Lazzarino G, Tavazzi B, Di Pierro D, Rasi G, Ravagnan G. Modifications of mitochondria in human tumor cells during anthracycline-induced apoptosis. Anticancer Res 2000; 20: 3383-94.